# Neural Damage and Anesthetic Treatment in the Preeclamptic Parturient; a Prospective Observational Study.

> **NCT03551223** · — · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Phosphopyruvate Hydratase

## Interventions

- **BIOLOGICAL:** Neuron specific enolase (NSE)

## Key facts

- **NCT ID:** NCT03551223
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03551223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03551223, "Neural Damage and Anesthetic Treatment in the Preeclamptic Parturient; a Prospective Observational Study.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03551223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
